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TumorigenesisPiwi-like gene family members (Piwil 1–4) are considered stem cell-associated genes/proteins. These are
expressed predominantly in germline cells, but are re-expressed in different tumors. Piwil 1–4 gene expression
has not previously been studied and correlated with clinicopathological parameters in renal cell carcinomas
(RCC). The Piwil 1–4 transcript levels were analyzed by quantitative real-time PCR in 73 clear cell RCC (ccRCC)
tissues and corresponding normal tissues. The transcript levels of Piwil 1, 2 and 4 were strongly and signiﬁcantly
correlated with each other, in both the tumor tissues and the normal tissues (P b 0.001; Spearman's rank test).
Piwil 4 gene expression was signiﬁcantly higher in the ccRCC tissues than that in the corresponding normal
renal tissues (P b 0.001; Wilcoxon signed-rank test). When the ccRCC patient cohort was divided according to
the median Piwil 1–4 expression into low- and high-expression groups and according to age into younger
(≤64 years) and older patient groups (N64 years), the younger patients displayed signiﬁcantly higher levels of
Piwil 1 mRNA in comparison to the older patients (P= 0.010; Fisher's exact test). Interestingly, Piwil 1 expres-
sion was left–right polarized in the normal tissues but not in the tumor tissues (P = 0.004; Fisher's exact test).
Altogether, associations were determined between the Piwi-like family member expression levels and clinico-
pathological parameters of ccRCC, suggesting a potential role for these genes/proteins in ccRCC diagnostics and
tumorigenesis as well as in renal tissue embryology.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The Piwi-like genes belong to the Argonaute gene family and com-
prise a family of four members in humans: Piwi-like 1 (Hiwi, Piwil 1),
Piwi-like 2 (Hili, Piwil 2), Piwi-like 3 (Piwil 3) and Piwi-like 4 (Hiwi 2,
Piwil 4) [1]. Piwi-like genes/proteins are expressed predominantly in
the germline. Piwi-like proteins can catalyze an ampliﬁcation loop
(ping-pong cycle) of small RNAs, the so-called piRNAs. Both piRNAs
and piwi-like proteins function as a piwi ribonucleoprotein complex
in transposon repression through target degradation and epigeneticcell carcinoma
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ights reserved.silencing (reviewed in [2,3]). Only Piwil 4 mRNA expression has been
described in several human somatic tissues [4]. In contrast, the expres-
sion of all four Piwil genes has been reported in prostate and pancreatic
tissues in rhesus macaques [5]. Importantly, Piwil gene re-expression is
common to many tumor entities [6]. Piwi-like protein overexpression
has been linked to cell physiological parameters in tumors, e.g., Piwil 1
protein to cell proliferation in gastric cancer [7] and Piwil 2 to anti-
apoptotic signaling in different cancers [8]. In addition, the detection
of Piwi-like proteins has been associated with clinical parameters and/
or poor prognosis in several cancers such as breast, cervical, ovarian, en-
dometrial, colon, colorectal, esophageal, gastric or liver cancer and glio-
mas, seminomas and sarcomas (reviewed in [6]). However, Piwi-like
gene mRNA expression has been studied to a much lesser extent in
tumor tissues. Piwil 1 mRNA was detected in seminomas, gastric, liver
and pancreatic cancers, gliomas and sarcomas [7,9–13]. Piwil 2 gene ex-
pression was detected in breast, cervical, prostate, gastrointestinal,
ovarian and endometrial cancer, as well as soft tissue sarcomas
[8,14,15] but it was not detected in bladder carcinomas or bladder
carcinoma cell lines [16]. Piwil 3 transcript expression has only been
validated in soft tissue sarcomas [14]. Nevertheless, the Oncomine
database (www.oncomine.org/) contains entries that suggest Piwil 3
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pression was previously reported in cervical cancer and soft tissue sar-
comas [14,17], and the Oncomine database also reports Piwil 4
expression in breast, liver and brain cancers. To date, a comparative
analysis of the impact of Piwi-like gene mRNA expression on tumori-
genesis and tumor progression in RCC has not yet been performed, al-
though Piwil 2 mRNA was reported in one tested RCC sample [8].
Therefore, we aimed to investigate the expression levels of all four
Piwil genes in ccRCC tissues and to analyze the correlations between
the expression levels of these genes with each other and with clinico-
pathological parameters.
2. Methods
2.1. Patients and clinical samples
Piwil 1, Piwil 2, Piwil 3 and Piwil 4mRNA expression levels were an-
alyzed in ccRCC and corresponding normal renal tissue samples from 73
non-selected ccRCC patients. Of these 73 ccRCC patients, all were stud-
ied for Piwil 1, Piwil 2 and Piwil 4, and 72 patients were studied for
Piwil 3 mRNA expression in tumor and corresponding normal tissues.
All patients in this study underwent radical nephrectomy at the Clinic
of Urology of the University Hospital Erlangen, Germany. This study
was performed in compliance with the Helsinki Declaration. The use
of tumor tissues for research was approved by the Internal Review
Boards of theMedical Faculty of the University Clinic of Erlangen. All pa-
tients gave written informed consent.
The median age of the patients at surgery was 65 years (range,
39–88 years). Themedian follow-up time after primary tumor resection
was 24 months (range, 0–56 months). During the follow-up period, 18
of the 73 patients (25%) died. The tumors were staged and graded ac-
cording to the TNM Classiﬁcation of Malignant Tumors [18]. A detailed
description of the ccRCC patients' clinicopathological data is given in
Table 1.
2.2. Determination of Piwil mRNA tissue expression levels by quantitative
PCR
All tissue sampleswere provided by the tissue bio-repository (stored
at −80 °C) at the Comprehensive Cancer Center (CCC), Erlangen-
Nürnberg, University Hospital Erlangen. Hematoxylin and eosin-
stained tissue sectionswere reviewed by an experienced uropathologist
(TTR). Only tumor tissue samples thatwere composed ofmore than 70%
cancer cells were included in the study. Normal control tissues that
comprised the renal cortex, including parts of the normal tubular sys-
tem, were derived from the opposite pole of the nephrectomy speci-
men. RNA extraction was performed with Trizol reagent (Ambion/Life
Technologies, Darmstadt, Germany) according to the manufacturer'sTable 1
Relationships between clinicopathological parameters and Piwil gene family member mRNA e
Clinicopathological parameters No. cases Piwil 1 low/high No. cases Piw
Age 73 P = 0.010 73 P =
≤64 years 37 12/25 35 17/
N64 years 36 23/13 38 20/
Tumor grade 72 P = 0.256 72 P =
1 + 2 51 24/27 51 26/
3 + 4 21 13/8 21 11/
Tumor stage 73 P = 0.854 73 P =
pT1 + 2 48 25/23 48 24/
pT3 + 4 25 12/13 25 13/
Localization 72 P = 0.355 72 P =
Left 33 19/14 33 17/
Right 39 18/21 39 20/
Patient status 73 P = 1.000 73 P =
Alive 55 28/27 55 29/
Dead 18 9/9 18 8/1
Statistical analysis was performed with Fisher's exact test. Signiﬁcant values are marked in bolinstructions. All RNA preparationswere treatedwith RNase-free DNaseI
(Roche, Mannheim, Germany). RNA isolation quality, cDNA preparation
and qRT-PCR quality were checked according to the MIQE guidelines as
suggested by Bustin et al. [19] and are described in Supplementary data
1. RNA yields and puritywere determinedwith amicroliter spectropho-
tometer (NanoDrop 1000; Thermo Scientiﬁc, Wilmington, DE). cDNA
synthesiswas performedwith theDynamo cDNASynthesis Kit (Thermo
Scientiﬁc) according to the manufacturer's instructions. Brieﬂy, 1 μg of
total RNA was reverse-transcribed in a total volume of 20 μl and was
used as template cDNA in subsequent PCR reactions. Quantitative PCR re-
actions were performed in a total volume of 10 μl, using gene-speciﬁc
primers and hybridization probes for Piwil 1 (Hs01041737_m1), Piwil
2 (Hs00216263_m1), Piwil 3 (Hs00908825_m1) and Piwil 4
(Hs00381509_m1) that were purchased from Applied Biosystems
(Applied Biosystems, Foster City, CA, USA). To allow relative quantiﬁca-
tion, each sample was analyzed in parallel for the expression of speciﬁc
Piwil transcripts and the endogenous reference gene HPRT1
(Hs99999909_m1, Applied Biosystems). The quantitative PCR reactions
were performed in 96-well plate format with the StepOne plus real-
time PCR system (Applied Biosystems; Supplementary data 1). The rela-
tive Piwil transcript expression levels were calculated according to the
ΔΔCt method [20] in which one sample served as reference.
2.3. Statistical analysis
Correlations between the continuous biological markers variables
were calculated with Spearman's rank correlation test (rs). Differences
between the Piwil member mRNA expression levels in malignant vs.
normal tissues from ccRCC patients were estimated with the Wilcoxon
signed-rank test and between different age groups with the Mann–
Whitney U-test. Relationships between the biological marker expres-
sion levels and the clinicopathological parameters were assessed with
Fisher's exact test. Speciﬁcally, the Piwil member median expression
levels were used to separate samples into low- and high-expression
groups (Table 2). Receiver operating curve (ROC) analyses were per-
formed to determine the ability of mRNA expression values to distin-
guish between tumor and normal tissue samples. All calculations were
performed with the SPSS 21 statistical package (SPSS-Science, Chicago,
IL, USA). P-values b 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Piwil member mRNA expression levels in malignant and normal tissues
from renal cell carcinoma patients
The median-normalized relative Piwil 1, Piwil 2, Piwil 3 and Piwil 4
mRNA expression levels in tumor tissues were 2.70 (0.00–259.12),
2.15 (0.01–39.55), 0.92 (0.00–637.39) and 16.93 (0.00–142.95),xpression levels in tumor tissues from renal cell carcinoma patients.
il 2 low/high No. cases Piwil 3 low/high No. cases Piwil 4 low/high
0.816 72 P = 0.638 73 P = 0.352
18 35 16/19 35 15/20
18 37 20/17 38 21/17
0.648 71 P = 1.000 72 P = 0.898
25 50 25/25 51 25/26
10 21 10/11 21 11/10
1.000 72 P = 0.593 73 P = 0.566
24 47 22/25 48 22/26
12 25 14/11 25 14/11
1.000 71 P = 0.813 72 P = 0.344
16 32 17/15 33 19/14
19 39 19/20 39 17/22
0.595 72 P = 0.786 73 P = 1.000
26 54 26/28 55 27/28
0 18 10/8 18 9/9
d.
Table 2
Relative Piwil family member mRNA expression levels in malignant and corresponding
normal tissues from ccRCC patients.
No. patients Mediana Range
Piwil 1 P = 0.089
Malignant tissue 73 2.70 0.00–259.12
Normal tissue 70 4.17 0.00–215.47
Piwil 2 P = 0.914
Malignant tissue 73 2.15 0.01–39.55
Normal tissue 70 1.75 0.00–23.89
Piwil 3 P = 0.923
Malignant tissue 72 0.92 0.00–637.39
Normal tissue 70 0.67 0.00–525.84
Piwil 4 P b 0.001
Malignant tissue 73 16.93 0.00–142.95
Normal tissue 70 5.87 0.00–70.75
a P-values were estimated with the Wilcoxon signed-rank test. Signiﬁcant value is
marked in bold.
Fig. 1.Box plot: Piwil 1 gene expression and age at diagnosis. Piwil 1 expression levels
were signiﬁcantly different between the two age groups (≤64 years vs. N64 years)
when the patients were separated according to the median age (P = 0.022; Mann–
Whitney U-test). When the ccRCC patients were further separated according to medi-
an Piwil 1 mRNA expression in patients with low or high expression, signiﬁcant dif-
ferences were observed in both groups when they were compared according to age
(P = 0.010; Fisher's exact test).
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2–4 were lower in normal tissues than that in tumor tissues. However,
the levels of Piwil 1 were somewhat higher in normal tissues. We
detected the following normalized mRNA expression values for Piwil
1–4 in normal tissues median (range): 4.17 (0.00–215.47), 1.75
(0.00–23.89), 0.67 (0.00–525.84) and 5.87 (0.00–70.75) (Table 2).
3.2. Relationships between Piwil member mRNA expression levels in
malignant and normal tissues from clear cell renal cell carcinoma patients
The relative Piwil gene family member mRNA expression levels in
themalignant tissue were strongly and signiﬁcantly positively correlat-
ed with each other (bivariate linear correlation analysis; Spearman's
Rho test). The relative Piwil 1 mRNA expression levels correlated signif-
icantly with those of Piwil 2 (rs = 0.438; P b 0.001) and Piwil 4 (rs =
0.375; P=0.001). Additionally, a signiﬁcant positive correlation was
observed between the relative Piwil 2 mRNA expression levels and
those of Piwil 4 (rs = 0.785; P b 0.001) and weakly with Piwil 3
(rs = 0.240; P = 0.042; Supplementary Table 1). When we com-
pared the Piwil 1–4 mRNA expression levels in normal tissues, the asso-
ciations between Piwil 1, 2 and 4 were comparable to those in the
tumor tissues. The relative Piwil 1mRNA expression levels correlated sig-
niﬁcantly with those of Piwil 2 (rs = 0.485; P b 0.001) and Piwil 4 (rs =
0.464; P b 0.001). Additionally, the Piwil 2 transcript levels correlated sig-
niﬁcantly with those of Piwil 4 (rs = 0.527; P b 0.001; Supplementary
Table 1).
A comparison of the Piwil 4 mRNA expression levels in malignant
and normal tissues revealed that the transcript levels were signiﬁcantly
higher in the malignant tissue samples (P b 0.001; Wilcoxon signed-
rank test; Table 2). An ROC analysis, using themedian Piwil 4mRNA ex-
pression (11.08) as the cutoff value, yielded a sensitivity of 67.1% and a
speciﬁcity of 67.1% for discriminating between malignant and corre-
sponding normal tissues (P b 0.001). The area under the curve was
0.746 (95% CI = 0.665–0.827; Supplementary Fig. 1). However, we
found no signiﬁcant differences in the Piwil 1, Piwil 2 and Piwil 3
mRNA expression levels between the malignant and corresponding
normal ccRCC tissues (data not shown).
3.3. Associations between Piwil 1 mRNA expression levels in tumor tissues
and renal cell carcinoma patients clinicopathological data
For the statistical analyses, all Piwil member expression levels were
stratiﬁed according to their median values to separate ccRCC patients
into groups with low and high tumor expression of Piwil 1–4 mRNA
(Tables 1 and 2).
We found no associations between clinicopathological parameters
such as the tumor stage, tumor grade or survival (overall and disease-
speciﬁc survival) and Piwil 1–4 gene expression (data not shown).
However, we detected a signiﬁcant association between the age atdiagnosis and the Piwil 1 transcript levels. Patients were stratiﬁed into
two groups according to the median age at diagnosis to form groups
of ≤64 years and N64 years. The younger ccRCC patient group
(≤64 years) displayed signiﬁcantly higher expression levels of Piwil 1
mRNA compared to the older group (N64 years; P = 0.010; Fisher's
exact test; Fig. 1). However, there were no signiﬁcant differences be-
tween the two age groups with respect to Piwil 2, Piwil 3 and Piwil 4
mRNA expression (data not shown). Similarly, patients with high
Piwil 1 mRNA expression levels were younger at diagnosis than those
with low Piwil 1 transcript levels (60.0 vs. 68.0 years, respectively). In
summary, the ccRCC patients with high Piwil 1 expression levels expe-
rienced tumor onset 8 years earlier than did the group with low tumor
expression of Piwil 1.
3.4. Associations between Piwil 1 mRNA expression levels in normal renal
tissue and left–right polarity
While incorporating additional information about the normal tissue
locations, we detected an association between the Piwil 1 expression
levels in normal renal tissues and the tissue location, such that the
Piwil 1 transcript levels were signiﬁcantly higher in normal tissues de-
rived from the right-sided kidneys than from left-sided kidneys (P =
0.001;Mann–WhitneyU-test). After dividing the normal tissues accord-
ing to the median Piwil 1 expression to form low- and high-expression
groups, we detected also a difference between the left- or right-sided
origins of the normal tissues (P= 0.004; Fisher's exact test). However,
similar associations with left–right polarity were not detected for Piwil
2–4 in the normal tissues or for any of the Piwil gene members in the
tumor tissues.
4. Discussion
In this study, the Piwil 1–4 expression levels were analyzed in ccRCC
tissues and corresponding normal tissues and were correlated with
each other as well as with histomorphological and clinicopathological
parameters. We found strong, signiﬁcant positive correlations between
themRNA levels of Piwil 1, 2 and 4, but not Piwil 3, in tumor tissues. Ad-
ditionally, strong signiﬁcant positive associations between the tran-
script levels of Piwil 1, 2 and 4 were detected in normal renal tissues.
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patients, in whom signiﬁcant correlations were detected between
Piwil 2 and Piwil 4 expression levels in tumor tissues and in tumor-
adjacent non-malignant tissues ([14] and unpublished results). Cur-
rently, it is not known whether the Piwil gene family members can in-
teract with each other or if they are regulated in a concerted manner.
The signiﬁcant correlations between the Piwil 1, 2 and 4 mRNA levels
in the normal renal tissues suggest a general rather than a tumor-
speciﬁc interaction or regulation.
The expression levels of all Piwil family members, with the excep-
tion of Piwil 1, were higher in the tumor tissues than that in the corre-
sponding normal renal tissues. However, only the expression levels of
Piwil 4 differed signiﬁcantly between the corresponding malignant
and normal renal cell tissue. A former study of STS patients also revealed
higher Piwil 2–4mRNA expression levels in tumor tissues, compared to
normal tissues, but these differences were not signiﬁcant [14]. Differ-
ences in expression between tumor and non-malignant tissues and
therefore a diagnostic impact of Piwil mRNA expression have been re-
ported in two other tumor entities. Piwil 1 (Hiwi) mRNA levels were
signiﬁcantly higher in hepatocellular carcinomas than that in adjacent
normal hepatic tissues [21]. Furthermore, Piwil 2 transcript levels
were signiﬁcantly increased in papillary thyroid carcinomas compared
to matched adjacent non-cancerous epithelium [22].
We did not detect signiﬁcant associations between the Piwil 1–4 ex-
pression levels and the ccRCC patients' clinicopathological parameters
(including survival), except for the age at diagnosis. Signiﬁcantly higher
Piwil 1mRNA expression levels were detected in the younger ccRCC pa-
tients after the patients were separated according to the median age at
diagnosis (≤64 years vs. N64 years). Our results show that ccRCC pa-
tients with higher Piwil 1 transcript levels had a signiﬁcantly earlier
age of tumor onset (8 years) than did patients with lower tumor tran-
script levels, suggesting a role for Piwil 1 in ccRCC tumorigenesis. How-
ever, no correlationswere found between the Piwil 1 protein expression
and the ages of cervical or hepatocellular carcinoma patients [21,23].
The following different roles have been suggested for Piwi-like proteins
during tumorigenesis: transcriptional silencing of tumor-suppressing
genes through epigenetic mechanisms, post-transcriptional regulation
of oncogenes and tumor suppressor genes, regulation of genomic stabil-
ity and promotion of cell proliferation in cancer cells, leading to aneu-
ploidy during mitosis (reviewed in [6]). Practical evidence that Piwil 1
(Hiwi) can function in a pro-tumorigenic manner was recently present-
ed. The overexpression of Hiwi in sarcoma precursors inhibited their
differentiation in vitro and generated sarcomas in vivo. The authors re-
ported that Hiwi-associated DNA hyper-methylation with subsequent
genetic and epigenetic changes favored a tumorigenic state [24].
An interesting resultwas the signiﬁcantly different Piwil 1mRNAex-
pression levels that were measured in normal renal tissues that origi-
nated on either the left- or the right-handed side. Interestingly, this
association was not detected in tumor tissues, regardless from which
body site the tumors originated. Because our ﬁndingwas related to nor-
mal tissue alone, it indicates a role for Piwil 1 in the regulation or imple-
mentation of left–right polarity in the kidney and possibly in the whole
human body. We are only able to offer a hypothesis to explain this ef-
fect. The bone morphogenic protein (Bmp) signaling pathway is crucial
for inducing and maintaining dorsal–ventral patterning equilibrium
(reviewed in [25]). Zili (thehomolog of Piwil 2 in zebraﬁsh) antagonizes
Bmp signaling to regulate dorsal–ventral patterning during early em-
bryogenesis in zebraﬁsh [25]. However, Ziwi expression (the homolog
of Piwil 1 in zebraﬁsh) is only speciﬁc to the gonads in adult zebraﬁsh
[26]. Furthermore, Bmp signaling pathway regulates left–right axis for-
mation in chick embryos [27]. Therefore, it is tempting to speculate that
Piwi-like genes/proteins might have an impact on body polarity by in-
terfering with bone morphogenetic proteins. Piwi-like 2 might affect
the dorsal–ventral axis, whereas Piwi-like 1 might instead play a role
in the induction or maintenance of left–right polarity. However, further
studies are necessary to test this hypothesis.In summary, Piwil transcript levels can associate with each other, as
shown for Piwil 1, 2 and 4, andwith the age of tumor onset (Piwil 1), or
they can differ between tumor and normal tissues (Piwil 4) and be-
tween the left and right kidney (Piwil 1) in normal tissues. Therefore,
Piwil familymember gene expression has a potential role in ccRCC diag-
nostics and tumorigenesis as well as the embryology of renal and possi-
bly other tissues.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2014.01.014.Acknowledgements
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